Literature DB >> 15895287

Highly polymorphic human CYP4A11 gene.

Byeong Hoon Cho1, Byung Lae Park1, Lyoung Hyo Kim1, Hyun Sub Chung1, Hyoung Doo Shin2.   

Abstract

The cytochrome P450 (CYP) is a monooxidase, which regulates metabolism of drugs and fatty acids in the liver and kidney. Among isoforms of the CYP4A subfamily, CYP4A11 is a major lauric acid (medium-length fatty acids) omega hydroxylase and is involved in the balance of lipids in the human liver. We performed direct DNA sequencing in 24 unrelated Korean individuals in the whole gene, including the 1-kb upstream region of CYP4A11. Seventy sequence variants were identified: six in exons, including two nonsynonymous SNPs; 60 in introns; and four in 3'UTR. In comparison with SNPs enrolled in the SNP database (dbSNP) of the National Center for Biotechnology Information (NCBI), 26 novel polymorphisms (24 in introns and two in 3'UTR) were identified in Korean subjects (n=24). The distributions of polymorphisms confirmed were significantly different from those in the dbSNP of the NCBI. Information clarified in this study would provide valuable for further studies, including genetic association studies for various diseases and drug responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895287     DOI: 10.1007/s10038-005-0245-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.

Authors:  K Kawajiri; K Nakachi; K Imai; A Yoshii; N Shinoda; J Watanabe
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

2.  Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11.

Authors:  F Adas; J P Salaün; F Berthou; D Picart; B Simon; Y Amet
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

3.  Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11.

Authors:  J M Lasker; W B Chen; I Wolf; B P Bloswick; P D Wilson; P K Powell
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 4.  Cytochrome P450 4A fatty acid omega hydroxylases.

Authors:  R T Okita; J R Okita
Journal:  Curr Drug Metab       Date:  2001-09       Impact factor: 3.731

5.  Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.

Authors:  I H Hanna; S Dawling; N Roodi; F P Guengerich; F F Parl
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

Authors:  T Shimada; H Yamazaki; M Mimura; Y Inui; F P Guengerich
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

Review 7.  Possible role of cytochromes P450 in lupus erythematosus and related disorders.

Authors:  R A McKinnon; D W Nebert
Journal:  Lupus       Date:  1994-12       Impact factor: 2.911

8.  Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney.

Authors:  S Imaoka; H Ogawa; S Kimura; F J Gonzalez
Journal:  DNA Cell Biol       Date:  1993-12       Impact factor: 3.311

Review 9.  Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.

Authors:  Songtao Yu; Sambasiva Rao; Janardan K Reddy
Journal:  Curr Mol Med       Date:  2003-09       Impact factor: 2.222

10.  Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity.

Authors:  Jason R Baker; Soisungwan Satarug; Robert J Edwards; Michael R Moore; David J Williams; Paul E B Reilly
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

View more
  3 in total

1.  Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.

Authors:  Hu Ding; Guanglin Cui; Lan Zhang; Yujun Xu; Xunna Bao; Yuanchao Tu; Bin Wu; Qi Wang; Rutai Hui; Wei Wang; Ryan T Dackor; Grace E Kissling; Darryl C Zeldin; Dao Wen Wang
Journal:  Pharmacogenet Genomics       Date:  2010-03       Impact factor: 2.089

2.  Association between the CYP4A11 T8590C variant and essential hypertension: new data from Han Chinese and a meta-analysis.

Authors:  Hua-Cheng Yan; Jun-Hua Liu; Jian Li; Bao-Xia He; Liang Yang; Jian Qiu; Liang Li; Da-Peng Ding; Lei Shi; Shu-Jin Zhao
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

3.  Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line.

Authors:  Hye Ja Lee; Mi Kyung Park; Young Ran Park; Donghak Kim; Chul-Ho Yun; Young-Jin Chun; Hee Jung Shin; Han Sung Na; Myeon Woo Chung; Chang Hoon Lee
Journal:  Toxicol Res       Date:  2011-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.